TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Pembrolizumab and Paclitaxel in Patients with HR+/HER2- Breast Cancer with HER2-Enriched or Basal-like Subtypes.

Benedetta Conte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.